A study has identified specific cancer-associated fibroblasts (CAFs) as key drivers of invasion and progression in aggressive Thyroid Cancer. By mapping the tumor stroma, researchers found that these cells create a microenvironment that promotes metastasis and resistance to treatment.
The researcher used single-cell sequencing and spatial transcriptomics to analyze 81 patient samples, comparing slow-growing tumors with lethal variants, including anaplastic thyroid cancer. This approach allowed them to pinpoint the CAFs at the “leading edges” of tumors that help cancer cells invade surrounding tissue.
These findings highlight CAFs as potential targets for new therapies, especially when surgery fails or the cancer returns. Researchers Vivian Weiss and Ryan Belcher are also studying how these insights apply to pediatric patients, who often experience more aggressive metastasis. The study represents a step toward precision oncology in thyroid cancer, focusing on molecular markers that predict which tumors are likely to become life-threatening.